Noting that it had the appropriate means to develop the omicron mutant vaccine and was ready to develop an updated version of its Cofid-19 "AstraZeneca vaccine if necessary, Oxford University said today that there was no evidence that currently available vaccines against the corona virus could not prevent the infection of the omicron mutant.

Oxford University indicated that there is limited data on omicron to date and that it will carefully assess the impact of the new mutant on the vaccine.

In a statement, she said: "Despite the emergence of new mutants over the past year, vaccines have continued to provide very high levels of protection against severe diseases and there is still no evidence that Omicron is completely different."

She went on to explain: "However, we have the tools and processes for the rapid development of the Cofid-19 vaccine if necessary."

Earlier, the president of Moderna Pharmaceutical Company said that anti-Cofid-19 vaccines are not as likely to be as effective with the mutated Omicron strain of Corona virus as with the Delta strain.

These statements raised new concern in financial markets about the course of the pandemic.

For her part, the head of the European Union medical agency said they were ready to deal with the new omicron mutant of the corona virus.

She noted that it would take two weeks to see whether or not the current COFID-19 vaccines would be able to handle it.